Fund moves

Zimmer Biomet (ZBH): Hotchkis & Wiley Capital Management LLC reduced its stake -31K shares

Hotchkis & Wiley Capital Management LLC reduced its stake in Zimmer Biomet, per its Q2 2026 13F.

2.76M
Shares reported · -31K vs prior quarter
0.69%
Disclosed portfolio weight
$238M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 20, 2026Federal contract · $114K obligatedDepartment of Defense awarded Zimmer Biomet: $114K obligated to date
  2. Mar 27, 2026CongressDisclosed purchase of ZBH — reported range $1,001 - $15,000
  3. Mar 31, 2026Federal contract · $120K obligatedDepartment of Veterans Affairs awarded Zimmer Biomet: $120K obligated to date
  4. Jun 16, 2026FDAFDA device clearance: Z1 Hip System
  5. Jun 16, 2026FDAFDA device clearance: Augment Off-Axis Instrument System
  6. Jun 26, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
  7. Jul 1, 2026FDAFDA device clearance: OSSTM Orthopedic Salvage System
  8. Jul 1, 2026FDARecall: Intramedullary Bone Saw Blade Assembly Model/Catalog Number: 475625 Product Description: Intramedullary Bone Saw Blade Assembly 13mm
  9. Jul 1, 2026FDARecall: Intramedullary Bone Saw Blade Assembly Model/Catalog Number: 475620 Product Description: Intramedullary Bone Saw Blade Assembly 12mm
  10. Jul 1, 2026FDARecall: Intramedullary Bone Saw Blade Assembly Model/Catalog Number: 475635 Product Description: Intramedullary Bone Saw Blade Assembly 15mm
  11. Jul 1, 2026FDARecall: Intramedullary Bone Saw Blade Assembly Model/Catalog Number: 475640 Product Description: Intramedullary Bone Saw Blade Assembly 16mm
  12. Jul 1, 2026FDARecall: Intramedullary Bone Saw Blade Assembly Model/Catalog Number: 475630 Product Description: Intramedullary Bone Saw Blade Assembly 14mm
  13. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  14. Aug 11, 2026Federal contract · $690K obligatedDepartment of Veterans Affairs awarded Zimmer Biomet: $690K obligated to date
  15. Aug 12, 20265% stakeCapital International Investors reported a passive stake (13G) of 6.4%
  16. Aug 13, 20265% stakeDodge & Cox reported a passive stake (13G) of 12.5%

What came next

  1. Aug 24, 2026FDAFDA device clearance: Zimmer Biomet OSS™ Orthopedic Salvage System OsseoTi® Sleeves and Augments
  2. Sep 4, 2026InsiderOfficer sold ~$295K of ZBH shares in the open market
  3. Sep 8, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 8, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) notified Kevin Thornal, Group President, Global Businesses and the Americas, that his position is being restructured.”
  4. Sep 11, 2026InsiderOfficer sold ~$529K of ZBH shares in the open market
  5. Sep 23, 2026FDAFDA device clearance: G7® Acetabular System
  6. Sep 24, 2026FDAFDA device clearance: OsseoFit Stemless Shoulder System
  7. Sep 29, 2026Federal contract · $82K obligatedDepartment of Health and Human Services awarded Zimmer Biomet: $82K obligated to date
  8. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  9. Nov 5, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Zimmer Biomet

For Zimmer Biomet, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZBH page.

How this filing works

Explore the data

Common questions

What does this filing report about Zimmer Biomet (ZBH) stock?

Hotchkis & Wiley Capital Management LLC reduced its stake in Zimmer Biomet, per its Q2 2026 13F. Now 2.76M shares, $238M reported value, 0.69% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 14, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Zimmer Biomet recently?

For Zimmer Biomet, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the ZBH page.

Does this mean ZBH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Zimmer Biomet

Everything OQRO holds on this company is on its ZBH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data